阿尔法科技骨科
ATEC
10.46
-0.47
-4.30%
阿尔法科技骨科
US · ATEC
#2945 按市值排名
上市于 1970
10.46
-0.47
-4.30%
实时 - 追踪5344个代码 - 心跳于496秒前
· 2026-10-16 19:30
✦ 量化股权信号 计算方式说明
减持
- 最近一期（2026/Q3）披露持股的机构数量减少了2家。
- 机构持股总比例下降了1.3个百分点。
机构持股
- 机构持股比例
- 86.02% -1.34pp
- 机构数量
- 313 -2
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向一致机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。
机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。
持股人类型
Mutual Fund54.31%
Hedge Fund13.61%
Individual/Insider10.31%
VC/PE Fund6.73%
Public Company4.98%
Private Company4.65%
Government Pension Fund0.96%
Insurance Company0.37%
Sovereign Wealth Fund0.23%
Other3.85%
主要股东 截至 2026-06-30
BlackRock
7.33% · 11.33M 股
Squadron Capital, LLC
6.73% · 10.40M 股
Braidwell LP
4.23% · 6.53M 股
American Century Investment Management
4.22% · 6.52M 股
LS Power Development, LLC
3.93% · 6.07M 股
Vanguard Capital Management, LLC
3.87% · 5.97M 股
Patrick Miles
3.26% · 5.03M 股
BNPP Asset Management Holding
2.29% · 3.54M 股
State Street Global Advisors
2.25% · 3.48M 股
Emerald Advisers, LLC
2.18% · 3.36M 股
条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 22次买入 · 27次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| Patrick Miles | Chairperson & CEO | 3.26% |
| Ward Woods | Independent Director | 1.42% |
| Mortimer Berkowitz | Lead Independent Director | 0.79% |
| Craig Hunsaker | Executive VP of People and Culture | 0.77% |
| Evan Bakst | Independent Director | 0.74% |
| Quentin Blackford | Independent Director | 0.37% |
| David Pelizzon | Independent Director | 0.22% |
| David Demski | Independent Director | 0.19% |
| Scott Lish | Officer | 0.19% |
| Tyson Marshall | General Counsel | 0.18% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-09-13 | Thomas Carls | Executive Vice President, Data Intelligence & Strategy | Initial Statement of Beneficial | 0 | -- |
| 2026-09-09 | Patrick Miles | Chairperson & CEO | Open Market Acquisition | +115,000 | $8.81 |
| 2026-08-04 | Tyson Marshall | General Counsel | Automatic Disposition | -8,168 | $9.65 |
| 2026-06-10 | Karen McGinnis | Independent Director | Automatic Disposition | -6,050 | $8.01 |
| 2026-06-09 | David Demski | Independent Director | Other Acquisition | +32,012 | -- |
| 2026-06-09 | Mortimer Berkowitz | Lead Independent Director | Other Acquisition | +32,012 | -- |
| 2026-06-09 | Karen McGinnis | Independent Director | Other Acquisition | +32,012 | -- |
| 2026-06-09 | Keith Valentine | Special Advisor to the Board | Other Acquisition | +32,012 | -- |
| 2026-06-09 | David Pelizzon | Independent Director | Other Acquisition | +32,012 | -- |
| 2026-06-09 | Quentin Blackford | Independent Director | Other Acquisition | +32,012 | -- |
| 2026-05-10 | Keith Valentine | Special Advisor to the Board | Open Market Acquisition | +135,000 | $7.00–7.54 |
| 2026-04-06 | Tyson Marshall | General Counsel | Derivative Exercise and Sale | -23,393 | $2.69–11.03 |
| 2026-04-06 | Tyson Marshall | General Counsel | Derivative Exercise and Retained | +79,107 | $1.68–3.34 |
| 2026-03-12 | J. Koning | Chief Financial Officer | Automatic Disposition | -79,789 | $12.36 |
| 2026-03-12 | Scott Lish | Officer | Open Market Disposition | -260,535 | $12.30 |
| 2026-03-10 | David Sponsel | Executive Vice President of Sales | Automatic Disposition | -163,452 | $12.52 |
| 2026-03-08 | Craig Hunsaker | Executive VP of People and Culture | Other Disposition | -600 | -- |
| 2026-03-08 | Craig Hunsaker | Executive VP of People and Culture | Open Market Disposition | -82,765 | $12.45 |
| 2026-03-05 | Craig Hunsaker | Executive VP of People and Culture | Automatic Disposition | -33,602 | $12.22 |
| 2026-03-04 | Patrick Miles | Chairperson & CEO | Sale to Issuer | -219,749 | $12.57 |
Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 19:30:04 · 仅供参考，不构成投资建议，也未考虑您的具体情况。
阿尔法科技骨科 讨论区 0 条评论